| Dr Bettina Ault, MD | |
|
900 E 3rd St, Chattanooga, TN 37403-2101 | |
| (423) 778-5437 | |
| (423) 778-7507 |
| Full Name | Dr Bettina Ault |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Nephrology |
| Location | 900 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205892353 | NPI | - | NPPES |
| 3815047 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0210X | Pediatrics - Pediatric Nephrology | 18614 (Tennessee) | Primary |
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
An international team of scientists, including researchers from Baylor College of Medicine, has discovered mutations of gene IRF2BPL that are associated with a previously undiagnosed neurological disorder in seven unrelated individuals.
"It is in poor countries and communities, where health needs are greatest and physicians are scarce, that nurses take an even greater role in health care delivery, often serving as the sole providers in rural villages or urban slums," Sheila Davis, director of global nursing at Partners In Health, writes in a Huffington Post "Impact Blog" opinion piece, noting this is International Nurses Week.
QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bettina Ault, MD 900 E 3rd St, Chattanooga, TN 37403-2101 Ph: (423) 778-5437 | Dr Bettina Ault, MD 900 E 3rd St, Chattanooga, TN 37403-2101 Ph: (423) 778-5437 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
An international team of scientists, including researchers from Baylor College of Medicine, has discovered mutations of gene IRF2BPL that are associated with a previously undiagnosed neurological disorder in seven unrelated individuals.
"It is in poor countries and communities, where health needs are greatest and physicians are scarce, that nurses take an even greater role in health care delivery, often serving as the sole providers in rural villages or urban slums," Sheila Davis, director of global nursing at Partners In Health, writes in a Huffington Post "Impact Blog" opinion piece, noting this is International Nurses Week.
QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.
› Verified 3 days ago
Kathleen S Hunt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 910 Blackford St, Chattanooga, TN 37403 Phone: 423-778-6505 Fax: 423-778-3157 | |
Yolanda Spraggins, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1651 Gunbarrel Rd Ste 302, Chattanooga, TN 37421 Phone: 423-899-2904 Fax: 423-892-5058 | |
Jane S Catterton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 632 Morrison Springs Rd, Suite 300, Chattanooga, TN 37415 Phone: 423-877-4524 Fax: 423-875-5860 | |
Mr. Ricardo Federico Causo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6025 Lee Hwy, Ste. 447, Chattanooga, TN 37421 Phone: 423-490-1547 Fax: 423-490-1197 | |
Dr. Rachel A Nelson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7550 Goodwin Rd, Chattanooga, TN 37421 Phone: 423-894-3252 Fax: 423-894-2237 | |
Dr. William Woods Blake, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-6170 Fax: 423-778-6938 | |
Dr. Lisa Ann Lowery-smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-6170 Fax: 423-778-6938 |